據報小鵬汽車開發自動駕駛晶片 洽談向汽車製造商供貨
據英國《金融時報》引述小鵬汽車-W(09868.HK)(XPEV.US)董事長何小鵬透露,公司已開發自動駕駛晶片,正將其整合到大眾汽車(Volkswagen)部分車型中,計劃明年在內地推出。
何小鵬表示,開發晶片是一項長期承諾,小鵬汽車正在尋找長期合作夥伴,正在與大眾汽車和其他汽車製造商就使用該晶片進行磋商。
此外,報道引述大眾汽車方面透露,正與小鵬汽車聯合開發兩款汽車,將於明年上市。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.